Wenrong Xu
Papers
1
Total Citations
28
H-Index
1
About
Dr. Wenrong Xu is a pioneering thoracic surgeon whose research focuses on minimally invasive surgical approaches for lung cancer, particularly non-small cell lung cancer (NSCLC). Their most notable contribution is a landmark randomized controlled trial comparing robot-assisted thoracoscopic surgery (RATS) to traditional thoracotomy for c-N2 stage NSCLC, a patient population previously considered high-risk for robotic approaches. This 2019 study, with 28 citations, demonstrated that RATS offers superior short-term outcomes—including reduced blood loss, shorter hospital stays, and fewer complications—without compromising oncologic safety. By extending the evidence for robotic surgery beyond early-stage disease, Dr. Xu has helped redefine surgical standards for advanced NSCLC. Their work directly addresses a critical gap in thoracic oncology, showing that even patients with N2 nodal involvement can benefit from the precision and recovery advantages of robotic techniques. Dr. Xu’s research continues to shape clinical guidelines and inspire further investigation into robotic applications for complex thoracic malignancies, making them a key figure in advancing patient-centered, minimally invasive cancer care.
Research Focus
Key Achievements
Top Papers
- 1